• Clathrin-Mediated Entry of Grass Carp Reovirus: PI3K Inhibit

  2026-05-25

  Wang et al. (2018) provide a mechanistic dissection of type III grass carp reovirus (GCRV104) entry into host cells, demonstrating that clathrin-mediated endocytosis and PI3K activity are essential for infection. Their inhibitor analysis, including the use of Wortmannin, reveals actionable targets for virology and host-pathogen research.

• (R,S)-Anatabine for Alzheimer's: Protocols, Use-Cases, and T

  2026-05-25

  (R,S)-Anatabine offers a targeted approach to amyloid-beta reduction and inflammation modulation for advanced Alzheimer's disease research. This article delivers practical, evidence-based workflows, protocol enhancements, and troubleshooting strategies to maximize experimental success with this versatile neurodegeneration research compound.

• LY-411575: Gamma-Secretase Inhibitor for Advanced Disease Mo

  2026-05-24

  LY-411575 empowers researchers with nanomolar precision for dissecting amyloid beta production and Notch signaling in both neurodegeneration and cancer research. Its robust performance and proven workflow reliability unlock new avenues in disease modeling and immunotherapy strategies.

• Chrysin Potentiates Sunitinib Sensitivity by Inducing Ferrop

  2026-05-23

  This study demonstrates that chrysin, a natural flavonoid, significantly enhances the anti-tumor efficacy of sunitinib in renal cell carcinoma (RCC) by inducing ferroptosis via the PI3K/Akt/GPX4 pathway. These findings suggest a promising combination strategy to overcome sunitinib resistance in RCC models.

• Applied Use of PPT (Propyl Pyrazole Triol) in Estrogen Recep

  2026-05-22

  PPT (Propyl Pyrazole Triol) empowers researchers to dissect estrogen receptor alpha signaling with unmatched selectivity, streamlining workflows in cancer biology, developmental models, and gene expression studies. This article translates cutting-edge reference findings into practical protocols, comparative advantages, and troubleshooting strategies for maximizing the impact of APExBIO’s gold-standard reagent.

• Virus-Mimicking Particles Advance Extrahepatic mRNA Delivery

  2026-05-22

  This study introduces a self-assembling enveloped virus-mimicking particle (EVMP) platform that achieves efficient, targeted mRNA delivery to extrahepatic tissues such as lung and spleen. By modularly optimizing peptide and lipid components, the authors overcome hepatic tropism, demonstrating significant anti-tumor efficacy with IL-12 mRNA and establishing a versatile strategy for next-generation mRNA therapeutics.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-05-21

  Satir et al. (2020) demonstrate that partial inhibition of BACE1, the enzyme initiating amyloid-beta production, can significantly decrease amyloid-beta secretion without impairing synaptic transmission in cortical neurons. This finding supports the strategy of moderate BACE1 inhibition for Alzheimer's research, addressing safety concerns observed in previous clinical trials.

• Cationic Lipids Tune Immunogenicity in mRNA-LNP Vaccine Desi

  2026-05-21

  This study systematically investigates how cationic lipid incorporation into mRNA-lipid nanoparticle (LNP) vaccines modulates immunogenicity and efficacy. The findings reveal that classic cationic lipids can fine-tune immune activation and antitumor responses, offering practical strategies for optimizing mRNA-LNP vaccine formulations.

• Zosuquidar (LY335979) 3HCl: Data-Driven MDR Solutions for La

  2026-05-20

  This article guides biomedical researchers through real-world challenges in multidrug resistance (MDR) workflows, focusing on the reproducibility and sensitivity gains achieved with Zosuquidar (LY335979) 3HCl (SKU A3956). Integrating peer-reviewed evidence, practical scenarios, and vendor reliability analysis, it positions this P-gp inhibitor as an optimal choice for robust cytotoxicity and drug sensitization experiments.

• Optimizing Apoptosis Detection with Annexin V-Cy5/DAPI Kit (

  2026-05-20

  This article addresses real-world laboratory challenges in apoptosis and necrosis analysis, demonstrating how the Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255) delivers rapid, reproducible, and quantitative results for cell viability and cytotoxicity assays. Researchers will gain scenario-driven guidance on protocol optimization, data interpretation, and product selection, grounded in peer-reviewed evidence and best practices.

• Amyloid Beta-peptide (25-35): Precision in Neurotoxicity Mod

  2026-05-19

  Amyloid Beta-peptide (25-35) (human) is the gold-standard fragment for modeling Alzheimer's neurotoxicity and microglial polarization. This article delivers advanced workflow insights, troubleshooting strategies, and translational context—empowering researchers to harness the full reproducibility and mechanistic clarity of APExBIO's Aβ25-35 in neurodegenerative disease research.

• Nanoparticle Delivery of NAC Halts Ferroptosis in Osteoarthr

  2026-05-19

  This study introduces chondrocyte-targeted nanoparticles loaded with N-acetylcysteine (NAC) to protect articular cartilage and slow osteoarthritis progression by inhibiting ferroptosis through glutathione maintenance. The findings highlight a robust nanotherapy platform for disease modification, with translational promise for joint preservation.

• Translational Leverage: (R,S)-Anatabine for Amyloid and Beyo

  2026-05-18

  This thought-leadership article guides translational neuroscience researchers through the mechanistic and strategic value of (R,S)-Anatabine—a minor alkaloid with robust activity against amyloidogenic and inflammatory pathways. It contextualizes Anatabine’s role as a tool and potential therapeutic for Alzheimer’s disease within the evolving landscape of neurodegeneration research, weaving in lessons from recent skin biology advances and outlining future directions.

• Ruthenium Red (B6740): Precision Inhibition of Ca2+ Transpor

  2026-05-18

  Explore how Ruthenium Red (B6740) empowers next-generation calcium signaling research as a potent Ca2+ transport inhibitor. This in-depth article uniquely connects mechanotransduction, autophagy, and advanced assay design, setting it apart from previous reviews.

• Amyloid Beta-peptide (25-35): Unveiling Microglial Pathways

  2026-05-17

  Explore how Amyloid Beta-peptide (25-35) (Aβ25-35) uniquely models Alzheimer’s disease neurotoxicity by dissecting microglial signaling and polarization. This article delivers new insight into assay decisions and mechanistic understanding, advancing neurodegenerative disease research.

16192 records 1/1080 page Next 12345 下5页 Last page